Old Web
English
Sign In
Acemap
>
Paper
>
Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy.
Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy.
2021
Yuri Okada
Rumiko Izumi
Tatsuhiko Hosaka
Satoshi Watanabe
Tomomi Shijo
Naokazu Hatchome
Risa Konishi
Yuki Ichimura
Naoko Okiyama
Naoki Suzuki
Tatsuro Misu
Masashi Aoki
Keywords:
Coronavirus disease 2019
Dermatology
Dermatomyositis
Antibody
MEDLINE
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]